BofA Securities remains Neutral on Johnson & Johnson (JNJ): early Ico approval was 'modest upside'
Tweet Send to a Friend
BofA Securities analyst Jason M. Gerberry reiterated a Neutral rating and $253.00 price target on Johnson & Johnson (NYSE: JNJ)The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
